Tirzepatide: Dual Incretin Mechanism and What the Clinical Evidence Shows
Tirzepatide differs from most of the molecules discussed in this section. This is because it is no longer an investigational peptide in a regulatory gray area, but rather an FDA-approved drug marketed under the brand na…
Read full article